Sydney Morning HeraldGive and you shall receive – new rules give priority to organ donorsSydney Morning HeraldThis involved reaching agreement with Israel's influential but highly sceptical religious leaders on the definition of "brain death&q…
New analysis may help identify breast cancer patients who will benefit from …News-Medical.netA new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French resea…
Independent Online'Natural does not equal safe'Independent OnlineDr Ulbricht also warned that garlic supplements, which are taken to reduce blood pressure, can interfere with anti-clotting medications and the immunosuppressant drug cyclosporine…
5-month-old received this milestone transplant at Children's.
Corneal transplantationLaser Focus worldCorneal immunological privilege allows corneal transplantations to remain rejection free, without the use of prophylaxis, in about 80% of low-risk transplantations such as those for keratoconus.54 Corneal transpl…
Even at higher genetic heart risk, lifestyle helpsFox NewsThat means increased odds of both heart attack and heart failure. Heart failure is a chronic condition in which the heart can't pump blood efficiently enough to meet the body's demands -…
The Deal PipelineAbbott Pays Action $110M for Global Rights to Phase II-Stage Acute Kidney …Genetic Engineering NewsAbbott is paying Denmark's Action Pharma $110 million for global rights to develop and commercialize the latter's AP214, a Pha…
Gilead Sciences begins phase III trial of leukaemia drugZenopaThe first patient has been dosed as part of Study 116, a trial that will assess the safety and efficacy of the drug in combination with rituximab among 160 subjects across Europe and the US….
Lupus Nephritis: First ACR Guidelines PublishedMedscapeRituximab or calcineurin inhibitors should be considered if standard treatments fail." Dr. Hahn also noted that an algorithm for management of pregnant woman with active [LN] is included in th…
New biologics and biosimilars approval guidelines in MexicoThe Pharma LetterFor example, Probiomed already sells six non-originator biologics, including Kikuzubam (rituximab), which is Probiomed's version of Roche's Rituxan/MabThera (rituximab)…